See the latest Uniti Group Inc stock price (UNIT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Bristol Myers Squibb has expanded its push into radiopharma by licensing a prostate cancer therapy developed by Philochem for $350m upfront.

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its drug development and cell therapy operations.